TB-500 and Thymosin Beta-4: Analytical Context for the LKKTETQ Region
The cited analytical record describes TB-500 as an N-acetylated LKKTETQ sequence related to an active thymosin beta-4 region. This guide distinguishes that analytical context from full-length thymosin beta-4 biology.
The cited analytical record describes TB-500 as an N-acetylated LKKTETQ sequence related to an active region of thymosin beta-4. It should not be treated as identical to full-length thymosin beta-4, and the cited evidence does not establish human outcomes.
Scope
This guide interprets the cited analytical and biological-context records for TB-500 and thymosin beta-4 terminology.
What the cited record supports
The analytical study identifies N-acetylated LKKTETQ in an equine detection context and describes its relation to an active thymosin beta-4 region. The thymosin beta-4 review provides context for the full-length peptide.
Interpretation limits
A synthetic region and a full-length peptide are not interchangeable. Analytical detection and full-length biological context do not establish a human outcome, product equivalence, or personal-use conclusion.
Research-use boundary
This material is for laboratory research education and analytical-document interpretation only.